Peptriva Testing Methodology

The lab partner

Freedom Diagnostics, an independent third-party laboratory in Franklin, Tennessee, United States, is named on every published Peptriva certificate^[2]. The client of record is given as Peptriva Research, the report is signed by the Principal Chemist, and the samples behind the certificates currently on file were received on 30 June 2026 and reported on 2 July 2026^[1]. The laboratory has its own public web presence, which is what makes the name on a certificate checkable rather than decorative.

One thing this record does not claim about that laboratory is accreditation. No certificate, scope number, or accrediting body appears in anything Peptriva publishes, so this issue names the laboratory and stops there^[2]. Because Peptriva is the subject under review, the distinction between what is documented and what is asserted matters more here than anywhere else on the site^[8].

Is Peptriva third-party tested?

Yes, and the useful form of the answer is not the yes. Every vendor in this category says its material is tested. What separates the Peptriva record is where the requirement lives: a lot cannot become sellable stock until an independent certificate exists for it, and that is a condition in the code that creates inventory rather than a sentence in a policy page. In the purchase-order sync it reads lotClearedToSell = lotHasManufacturerCoa() AND lotHasIndependentCoa(), in apps/backend/src/lib/sync-po-to-medusa.ts. A lot missing either document never reaches the storefront.

What lab does Peptriva use?

Freedom Diagnostics of Franklin, Tennessee^[2]. There is one laboratory of record for the published certificates, not a rotation, and the same name appears on all fourteen. Fourteen certificates cover thirteen lots, because the lab solvent carries two accession numbers for its two separate tests. Twelve rows appear on the public ledger^[1].

The manufacturing facility that performs the first test is not named anywhere on this network. That is a commercial decision by Peptriva rather than an editorial one, it is disclosed on the transparency plate, and it costs the record something: half of the two-certificate rule rests on a document a reader cannot open.

The methodology

Two tests, separated by a shipment.

1. The production release. The manufacturing facility tests and releases the batch. That certificate is held on file and is not published.
2. The arrival re-test. When the lot reaches the United States distribution facility, a sample goes to the independent laboratory for a full re-test against the same panel. That certificate is the one published on the ledger^[1].
3. The release condition. Sellable stock is created only where both certificates are present. A lot with one of them stays out of stock.

The second test is the one that carries the evidential weight, because it is the one capable of disagreeing with the first. A production certificate describes material as it left the facility that produced it, certified by the party with an interest in it passing. An independent certificate describes the same material after it has been packed, shipped, and received somewhere else, tested by a party with no stake in the outcome.

The panel itself is five assays, and each one catches a different failure.

Identity is the assay discussed least and worth most: purity without identity is a precise number about an unknown. Net content is the assay most vendor certificates omit, and its absence is how a buyer can receive genuinely high-purity material and still be short of what the label promised. Appearance is the cheapest assay on the panel and the only one checkable without equipment^[1].

What does lot-level testing mean?

It means the unit being certified is the lot, not the product. A certificate that says a compound is 99 percent pure without naming a lot describes an idea. A certificate that names lot BC10-260504 and reports a figure against it describes a specific quantity of material that a specific buyer either received or did not^[1].

That is why every row of the ledger carries a lot number and every certificate carries a laboratory accession number. It is also why the release rule is expressed per lot: the question the system asks is not whether the product has ever been tested, but whether this lot has two certificates on it today.

What is USP <85>?

United States Pharmacopeia General Chapter <85>, Bacterial Endotoxins Test, is the standard the endotoxin assay on every Peptriva certificate is run against^[6]. The method is LAL, the specification is 0.05 EU/mL or lower, and the test is run in duplicate rather than once^[1].

Two boundaries on that result are worth stating. It is a contamination measure against a published standard, and it carries no implication about the material being suitable for anything. And it is not a sterility assay: none appears on this panel, and the published terms state the material is not sterile^[3].

Who is Freedom Diagnostics?

The independent third-party laboratory of record on every published Peptriva certificate, based in Franklin, Tennessee, United States, with its own public web presence^[2]. On the certificates it appears as the issuing laboratory, with Peptriva Research as the client of record and the Principal Chemist as signatory, and with an accession number that belongs to the laboratory's own document system rather than to Peptriva's^[1].

How many lots has Peptriva tested?

Thirteen, covered by fourteen certificates, with twelve rows published on the ledger^[1]. Eight of those lots are discussed on this network in full, with purity, lot number, accession number, and net content on the product quality plate. Four sit on the restricted tier described on the cover. One is the lab solvent, which is tested differently because it is a different kind of product.

The solvent lot, BA10-260000, carries two accession numbers, 2606300390 and 2606300391, covering microbial analysis by PCR, reported as no detectable microbial DNA, and endotoxin by LAL under USP <85>. Both pass. No purity assay applies to a solvent, so none is reported, and this is the one product cleared for sale on the independent certificate alone^[1][6].

The cadence

One round. Every independent certificate on file comes from the same submission window, received 30 June 2026 and reported 2 July 2026^[1]. Every-lot testing is currently a rule enforced in the order system, not a long series of repeated rounds, and the distinction is the most important limitation on this page.

Reproducibility is precisely the property a single round cannot demonstrate. No lot in this archive has been tested twice by the independent laboratory, so there is no second figure to compare a first against. A second submission, months after the first, on lots already tested once and published beside the originals, would convert the strongest claim in this record from a design argument into an evidentiary one. It has not happened, and nothing on this network is scored as though it had.

The verification mechanism

A reader who has taken delivery can audit the lot in four steps, none of which requires asking Peptriva anything.

1. Find the row. Open the certificate ledger and locate the lot. A lot in sellable stock with no independent certificate behind it is a failure of the release rule, and it is visible immediately^[1][5].
2. Match the lot number. The number on the vial should match the number on the ledger row. A mismatch means the certificate on file describes different material.
3. Match the accession number. This is the laboratory's own identifier for the report, printed on the certificate, and it is the field that distinguishes a transcription from an invention^[1].
4. Read net content and appearance. Both are checkable against what arrived: a declared mass, and a recorded physical description^[1].

Where a shipped batch fails any published certificate specification, the remedy is set out on the customer experience plate. A buyer may substantiate that failure with their own third-party laboratory report, which is the clause that makes the specification more than a number on a page^[3].